Riskpilot← Back to searchSign inGet full accessGASSMANN AS
ASActiveOrg 985214638Sparavollen 79, 3021 DrammenWholesale of chemical products · NACE 4685Est. 20031 employeeswww.gassmann.no
Revenue 2024
NOK 3M
+1% vs 2023
EBITDA margin
-14.5%
-75% vs 2023
Equity ratio
94.8%
Financial strength
Net profit 2024
NOK 20K
-91% vs 2023
| Revenue | NOK 3M | +1% |
| EBITDA | NOK -437K | -75% |
| Net profit | NOK 20K | -91% |
| Total assets | NOK 7,9M | -7% |
| Equity | NOK 7,5M | -4% |
| Employees | 1 | — |
Legal name
GASSMANN AS
Org number
985214638
Legal form
Aksjeselskap
NACE code
4685 · Wholesale of chemical products
Founded
3. februar 2003
Share capital
NOK 100 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder alene.
Company purpose
Selv, gjennom hel- eller deleide selskaper eller ved samarbeide med andre virksomheter å forestå salg og import av gass og annen virksomhet beslektet med denne.
Address
Sparavollen 79, 3021 Drammen
Website
www.gassmann.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 45 805 | 1 674 | 2 158 | 2 992 | 3 011 |
| Staff expenses | −285 | −38 | −602 | −791 | −714 |
| EBITDA | 12 464 | 541 | −306 | −249 | −437 |
| Depreciation & amort. | −16 | −180 | −143 | −143 | −42 |
| EBIT | 12 448 | 361 | −449 | −392 | −480 |
| Net financials | 96 | 3 946 | 1 903 | 623 | 499 |
| Profit before tax | 12 544 | 4 307 | 1 455 | 230 | 20 |
| Tax | 2 760 | 92 | −27 | −0 | −0 |
| Net profit | 9 784 | 4 214 | 1 482 | 230 | 20 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 14 765 | 8 424 | 9 044 | 8 526 | 7 904 |
| Equity | 10 512 | 7 407 | 8 039 | 7 769 | 7 489 |
| Long-term debt | 841 | 682 | 532 | 409 | 0 |
| Short-term debt | 3 412 | 334 | 472 | 348 | 415 |
| Total debt | 4 253 | 1 016 | 1 005 | 757 | 415 |
EBITDA margin
-14.5%
This company
15.8%
Market median
-192% vs market
20202024
Equity ratio
94.8%
This company
38.2%
Market median
+148% vs market
20202024
Return on equity
0.3%
This company
18.4%
Market median
-98% vs market
20202024
Net profit margin
0.7%
This company
8.1%
Market median
-91% vs market
20202024
Asset turnover
0.38×
This company
1.12×
Market median
-66% vs market
20202024
Debt / equity
0.06×
This company
0.62×
Market median
+90% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2021 | |
| Chairman | 2021 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
GASSMANN AS 
Vito Medical AsBoard members of GASSMANN AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Eli Helene Køste Winness | Board of Directors | 0 companies |
| Morten Forrestad Winness | Chairman | 0 companies |